JP2015505669A5 - - Google Patents

Download PDF

Info

Publication number
JP2015505669A5
JP2015505669A5 JP2014543455A JP2014543455A JP2015505669A5 JP 2015505669 A5 JP2015505669 A5 JP 2015505669A5 JP 2014543455 A JP2014543455 A JP 2014543455A JP 2014543455 A JP2014543455 A JP 2014543455A JP 2015505669 A5 JP2015505669 A5 JP 2015505669A5
Authority
JP
Japan
Prior art keywords
nktcl
jak inhibitor
jak3
jak1
jak
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014543455A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015505669A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2012/000444 external-priority patent/WO2013077814A2/en
Publication of JP2015505669A publication Critical patent/JP2015505669A/ja
Publication of JP2015505669A5 publication Critical patent/JP2015505669A5/ja
Pending legal-status Critical Current

Links

JP2014543455A 2011-11-25 2012-11-26 ナチュラルキラー/t細胞リンパ腫(nktcl)の感受性予測、診断および治療 Pending JP2015505669A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG201108800-2 2011-11-25
SG2011088002 2011-11-25
PCT/SG2012/000444 WO2013077814A2 (en) 2011-11-25 2012-11-26 Natural-killer/t-cell lymphoma (nktcl) susceptibility prediction, diagnosis and therapy

Publications (2)

Publication Number Publication Date
JP2015505669A JP2015505669A (ja) 2015-02-26
JP2015505669A5 true JP2015505669A5 (enExample) 2016-01-21

Family

ID=54257023

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014543455A Pending JP2015505669A (ja) 2011-11-25 2012-11-26 ナチュラルキラー/t細胞リンパ腫(nktcl)の感受性予測、診断および治療

Country Status (6)

Country Link
US (2) US20150292022A1 (enExample)
EP (1) EP2782562B1 (enExample)
JP (1) JP2015505669A (enExample)
CN (1) CN104220051B (enExample)
SG (2) SG11201402611WA (enExample)
WO (1) WO2013077814A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6416508B2 (ja) * 2014-06-05 2018-10-31 公益財団法人がん研究会 Nk/t細胞リンパ腫の検査方法
CN110392595A (zh) * 2016-12-09 2019-10-29 昂克免疫有限公司 改进的基于nk细胞的疗法
CN111479932A (zh) * 2017-10-06 2020-07-31 新加坡保健服务集团有限公司 治疗淋巴瘤的方法
CN108841869B (zh) * 2018-05-31 2022-05-06 上海交通大学医学院附属瑞金医院 一种斑马鱼nk/tcl肿瘤模型的构建方法及其应用
NL2037024B1 (en) * 2024-02-14 2025-08-22 Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis Janus kinase (JAK) inhibitors for treating cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE369844T1 (de) * 2000-01-24 2007-09-15 Genzyme Corp Inhibitoren des jak/stat-weges und deren verwendung zur behandlung von allgemeiner primärer osteoarthritis
CA2675534A1 (en) * 2006-01-20 2007-07-26 Cell Signaling Technology, Inc. Mutant jak3 kinase in human leukemia

Similar Documents

Publication Publication Date Title
JP6078211B2 (ja) 自閉症および自閉症の表現型に関連する遺伝子変化ならびに自閉症の診断および治療に対するその使用方法
Zheleznyakova et al. Epigenetic research in multiple sclerosis: progress, challenges, and opportunities
Juhila et al. MicroRNA expression profiling reveals miRNA families regulating specific biological pathways in mouse frontal cortex and hippocampus
JP2012511895A (ja) ヒト認知の原因となる遺伝子変異体及び診断標的及び治療標的としてのそれらを使用する方法
Li et al. Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers
JP2018523488A (ja) 自己免疫疾患の治療及び診断のために組み合わせて使用するための組成物及び方法
TWI619723B (zh) 探針、微陣列、探針群組、β地中海型貧血檢測套組、β血球蛋白基因變異檢測用套組、多態性檢測用微陣列探針對的評價方法以及基因型判別顯示程式
JP5775064B2 (ja) プロテアソーム阻害剤による治療に対する末梢性ニューロパシー応答を評価するためのバイオマーカー
JP2010528590A5 (enExample)
CN105658818A (zh) 遗传标记物预测醋酸格拉替雷反应
JP2015505669A5 (enExample)
JP2011528903A5 (enExample)
US20210180129A1 (en) Methods of predicting the development of amd based on chromosome 1 and chromosome10
Guardado-Estrada et al. A miRNome analysis at the early postmortem interval
Miliotis et al. Determinants of gastric cancer immune escape identified from non-coding immune-landscape quantitative trait loci
JP2021100420A (ja) Crhr1拮抗薬を用いた治療に対する反応の遺伝子予測因子
Minnicelli et al. Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma
JP2018516231A (ja) Crhr1拮抗薬を用いた治療に対する反応の遺伝子予測因子を用いた治療の方法
WO2011146788A2 (en) Methods of assessing a risk of developing necrotizing meningoencephalitis
JP4842256B2 (ja) 遺伝子一塩基多型解析によるアトピー性皮膚炎の相対罹患危険率の検出方法
WO2013008709A1 (ja) イヌの緑内障を診断する方法及びキット
Chakravorty et al. Implementation of exome sequencing assay
JPWO2014034952A1 (ja) がんに対する免疫療法の有効性の予測方法
Tchitchek et al. Expression sequence tag library derived from peripheral blood mononuclear cells of the chlorocebus sabaeus
Sieg et al. Comparative analysis of single-stranded and non-canonical DNA formation in human and other ape cells with telomere-to-telomere genomes